Regulation of the immune response by epidermal cytokines and neurohormones

Journal of Dermatological Science

Volumn 13, Issue 1, 1996, Pages 5-10

  Luger, T A ^a   Bhardwaj, R S ^a   Grabbe, S ^a   Schwarz, T ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Cytokine; Immune response; Neurohormone

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; COLONY STIMULATING FACTOR; CYTOKINE; INTERFERON; INTERMEDIN; NEUROHORMONE; PROOPIOMELANOCORTIN; SUBSTANCE P; TUMOR NECROSIS FACTOR;

ANIMAL CELL; CONTACT ALLERGY; EPIDERMIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0030272556     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/0923-1811(95)00485-8     Document Type: Review

References (51)

1. [1] Bos JD, Kapsenberg ML: The skin immune system: Progress in cutaneous biology. Immunol Today 14: 75-78, 1993.
2. [2] Luger TA, Schwarz T: The role of cytokines and neuroendocrine hormones in cutaneous immunity and inflammation. Allergy 50: 292-302, 1995.
3. [3] Romani N, Heufler C, Koch F, Topar G, Kämpgen E, Schuler G: Cytokines and Langerhans cells. In: Luger TA, Schwarz T, eds. Epidermal Growth Factors and Cytokines. New York: Marcel Dekker Inc., 1993: 345-364.
4. [4] Grabbe S, Luger TA: The skin as an immunological organ as well as a target for immune responses. In: Kater L, Baart de la Faille H, eds. Multi-Systemic Auto-Immune Diseases: An Integrated Approach. Amsterdam: Elsevier, 1995: 17-42.
5. [5] Riemann H, Grabbe S, Schwarz A, Aragane Y, Luger TA, Wysocka M, Kubin M, Trinchieri G, Schwarz T: In vivo application of an interleukin 12 antibody induces hapten specific tolerance. J Invest Dermatol 1995. 104: 571.
6. [6] Aragane Y, Riemann H, Bhardwaj RS, Schwarz A, Sawada Y, Yamada H, Luger TA, Kubin M, Trinchieri G, Schwarz T: IL-12 is expressed and released by human keratinocytes and epidermoid carcinoma cell lines. J Immunol 153: 5366-5372, 1994.
7. [7] Brunda MJ: Interleukin-12. J Leuk Biol 55: 280-288, 1994.
8. [8] Schwarz A, Grabbe S, Riemann H, Aragane Y, Simon M, Manon S, Andrade S, Luger TA, Zlotnik A, Schwarz T: In vivo effects of interleukin-10 on contact hypersensitivity and delayed-type hypersensitivity reactions. J Invest Dermatol 103: 211-216, 1994.
9. [9] Enk AH: Interleukin 10. In: Luger TA, Schwarz T, eds. Epidermal Growth Factors and Cytokines. New York: Marcel Dekker, Inc., 1993: 113-130.
10. [10] Kim J, Modlin RL, Moy RL, Dubinett SM, McHugh T, Nickoloff BJ, Uyemura K: IL-10 production in cutaneous basal and sqamous cell carcinomas. A mechanism for evading the local immune response. J Immunol 155: 2240-2247, 1995.
11. [11] Luger TA, Schwarz T: Effect of UV-light on cytokine and neuroendocrine hormone production by epidermal cells. In: Jung EG, Holick MF, eds. Biologic Effects of Light 1993, Berlin: Walter de Gruyter, 1994: 594-610.
12. [12] Finck BK, Chan B, Wofsby D: Interleukin 6 promotes murine lupus in NZB/NZWF1 mice. J Clin Invest 94: 585-591, 1994.
13. [13] Llorente L, Zou W, Levy Y, Richaud-Patin Y, Wijdenes J, Alcocer-Varela J, Morel-Fourrier B, Brouet JC, Alarcon-Segovia D, Galanaud P, Emilie D: Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med 181: 839-844, 1995.
14. [14] Blalock JE: The syntax of immune-neuroendocrine communication. Immunol Today 15: 504-511, 1994.
15. [15] Bhardwaj RS, Luger TA: Proopiomelanocortin production by epidermal cells: Evidence for an immune neuroendocrine network in the epidermis. Arch Dermatol Res 287: 85-90, 1995.
16. [16] Blalock JE: The immune system: Our sixth sense. The Immunologist 2: 8-15, 1994.
17. [17] Croitoru K, Ernst PB, Bienenstock J, Padol I, Stanisz AM: Selective modulation of the natural killer activity of murine intestinal intraepithelial leucocytes by the neuropeptide substance P. Immunology 71: 196-201, 1990.
18. [18] Calvo CF, Chavanel G, Senik A: Substance P enhances IL-2 expression in activated human T cells. J Immunol 148: 3498-3504, 1992.
19. [19] Nio DA, Moylan RN, Roche JK: Modulation of T lymphocyte function by neuropeptides. Evidence for their role as local immunoregulatory elements. J Immunol 150: 5281-5288, 1993.
20. [20] Ansel JC, Brown JR, Payan DG, Brown MA: Substance P selectively activates TNF-alpha gene expression in murine mast cells. J Immunol 150: 4478-4485, 1993.
21. [21] Freidin M, Kessler JA: Cytokine regulation of substance P expression in sympathetic neurons. Proc Natl Acad Sci USA 88: 3200-3203, 1991.
22. [22] Pincelli C, Fantini F, Massimi P, Girolomoni G, Seidenari S, Giannetti A: Neuropeptides in skin from patients with atopic dermatitis: An immunohistochemical study. Br J Dermatol 122: 745-750, 1990.
23. [23] Kimball ES: Substance P, cytokines, and arthritis. Ann NY Acad Sci 594: 293-308, 1990.
24. [24] Johnston JA, Taub DD, Lloyd AR, Conlon K, Oppenheim JJ, Kevlin DJ: Human T lymphocyte chemotaxis and adhesion induced by vasoactive intestinal peptide. J Immunol 153: 1762-1768, 1994.
25. [25] Taylor AW, Streilein JW, Cousins SW: Immunoreactive vasoactive intestinal peptide contributes to the immuno-suppressive activity of normal aqueous humor. J Immunol 153: 1080-1086, 1994.
26. [26] Hosoi J, Murphy GF, Egan CL, Lerner EA, Grabbe S, Asahina A, Granstein RD: Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature 363: 159-163, 1993.
27. [27] Pincelli C, Fantini F, Massimi P, Giannetti A: Neuropeptide Y-like immunoreactivity in Langerhans cells from patients with atopic dermatitis. Int J Neurosci 51: 219-220, 1990.
28. [28] Asahina A, Moro O, Hosoi J, Granstein RD: Calcitonin gene-related peptide (CGRP) has specific effects on cAMP levels, B7-2 expression and function of antigen presenting cells. J Invest Dermatol 104: 566, 1995.
29. [29] Chang CH, Furue M, Tamaki K: B7-1 expression of Langerhans cells is up-regulated by proinflammatory cytokines, and is down-regulated by interferon-gamma or by interleukin-10. Eur J Immunol 25: 394-398, 1995.
30. [30] Asahina A, Hosoi J, Beissert S, Stratigos A, Granstein RD: Inhibition of the induction of delayed-type and contact hypersensitivity by calcitonin gene-related peptide. J Immunol 154: 3056-3061, 1995.
31. [31] Reichlin S: Neuroendocrine-immune interactions. N Engl J Med 329: 1246-1253, 1993.
32. [32] Catania A, Lipton JM: Alpha-melanocyte stimulating hormone in the modulation of host reactions. Endocr Rev 14: 564-576, 1993.
33. [33] Burbach JPH, Wiegant VM: Gene expression, biosynthesis and processing of proopiomelanocortin peptides and vasopressin. In: de Wied D, ed. Neuropeptides: Basics and Perspectives. Amsterdam: Elsevier. 1990: 45-103.
34. [34] Marcinkiewicz M, Day R, Seidah NG, Chretien M: Ontogeny of the prohormone convertases PC1 and PC2 in the mouse hypophysis and their colocalization with corticotropin and alpha-melanotropin. Proc Natl Acad Sci USA 90: 4922-4926, 1993.
35. [35] Schauer E, Trautinger F, Köck A. Bhardwaj RS, Simon M, Schwarz A, Ansel JC, Schwarz T, Luger TA: Proopiomelanocortin derived peptides are synthesized and released by human keratinocytes. J Clin Invest 93: 2258-2262, 1994.
36. [36] Lunec J, Pieron C, Sherbet GV, Thody AJ: Alpha-melanocyte-stimulating hormone immunoreactivity in melanoma cells. Pathobiology 58: 193-197, 1990.
37. [37] Morhenn VB: The physiology of scratching: Involvement of proopiomelanocortin gene-coded proteins in Langerhans cells. Prog Neuro Endo Immun 4: 265-267, 1991.
38. [38] Farooqui JZ, Medrano EE, Boissy RE, Tigelaar RE, Nordlund JJ: Thy-1 + dendritic cells express truncated form of POMC mRNA. Exp Dermatol 4: 228-232, 1995.
39. [39] Mountjoy KG, Robbins LS, Mortrud MT, Cone RD: The cloning of a family of genes that encode the melanocortin receptors. Science 257: 1248-1251, 1992.
40. [40] Bhardwaj RS, Becher E, Mahnke K, Schwarz T, Luger TA: Modulation of alpha-melanocyte stimulating hormone receptor expression on human monocytes. J Invest Dermatol 104: 651, 1995.
41. [41] Star RA, Rajora N, Huang J, Chavez R, Catania A, Lipton JM: Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-MSH. Proc Natl Acad Sci USA 92: 8016-8020, 1995.
42. [42] Cannon JG, Tatro JB, Reichlin S, Dinarello CA: Alpha melanocyte stimulating hormone inhibits immunostimulatory and inflammatory actions of interleukin 1. J Immunol 137: 2232-2236, 1986.
43. [43] Mugridge KG, Perretti M, Ghiara P, Parente L: Alpha-melanocyte-stimulating hormone reduces interleukin-1 beta effects on rat stomach preparations possibly through interference with a type I receptor. Eur J Pharmacol 197: 151-155, 1991.
44. [44] Luger TA, Schauer E, Trautinger F, Krutmann J, Ansel J, Schwarz A, Schwarz T: Production of immunosuppressing melanotropins by keratinocytes. Ann NY Acad Sci 680: 567-570, 1993.
45. [45] Bhardwaj RS, Aragane Y, Becher E, Schwarz A, Riemann H, Schwarz T, Luger TA: Alpha-melanocyte stimulating hormone differentially regulates interleukin 10 production by human peripheral mononuclear cells. J Invest Dermatol 102: 586, 1994.
46. [46] Glinski W, Brodecka H, Glinska-Ferenz M, Kowalski D: Increased concentration of beta-endorphin in the sera of patients with severe atopic dermatitis. Acta Derm Venereol 75: 9-11, 1995.
47. [47] Smith EM, Hughes TKJ, Hashemi F, Stefano GB: Immunosuppressive effects of corticotropin and melanotropin and their possible significance in human immunodeficiency virus infection. Proc Natl Acad Sci USA 89: 782-786, 1992.
48. [48] Chowdrey HS, Lightman SL, Harbuz MS, Larsen PJ, Jessop DS: Contents of corticotropin-releasing hormone and arginine vasopressin immunoreactivity in the spleen and thymus during a chronic inflammatory stress. J Neuroimmunol 53: 17-21, 1994.
49. [49] Köck A, Schauer E, Schwarz T, Luger TA: Human keratinocytes synthesize and release neuropeptides such as α-MSH and ACTH. In: Meltzer M, Mantovani A, eds. Cellular and Cytokine Networks in Tissue Immunity. New York: John Wiley & Sons, Inc., 1991: 105-110.
50. [50] Aebischer I, Stämpfli MR, Zürcher A, Miescher S, Urwyler A, Frey B, Luger TA, White RR, Stadler BM: Neuropeptides are potent modulators of human in vitro immunoglobulin E synthesis. Eur J Immunol 24: 1908-1913, 1994.
51. [51] Grabbe S, Bhardwaj RS, Mahnke K, Schwarz T, Luger TA: Alpha-melanocyte stimulating hormone induces hapten-specific tolerance in mice. J Immunol 156 (in press): 1996.